It is interesting to note that HIF-1α inhibition using CTM impacted upon CLL cells in hypoxia, accelerating glutamine consumption and glutamate production, whereas diminishing glucose consumption and lactate production. Here, HIF1A is linked to B-cell chronic lymphocytic leukemia.